For Immediate Release SALIX VENTURES ANNOUNCES INVESTMENT IN ANCILLARY CARE MANAGEMENT SAN FRANCISCO, CALIFORNIA (November 14, 200) -- Salix Ventures announced today a $4.0 million investment as part of a $8.6 million Series B Preferred Stock financing in Ancillary Care Management of Los Angeles, California. Delphi Ventures, Validus Partners, and St. Paul Ventures, all Series A investors in the Company, also participated in the financing. As a result of this investment, Marty Felsenthal, a General Partner of Salix Ventures, will join Ancillary Care Management's Board of Directors. Ancillary Care Management provides outsourced services and systems to health plans to assist them in managing the cost and delivery of ancillary care. The Company primarily focuses on managing the rapidly rising costs of specialty biologics (high cost drugs administered by injection or infusion), home health services, durable medical equipment services, and home infusion services. ACM has developed proprietary workflow systems that allow it to manage authorization of services, claim submission, claim adjudication, claim status, pricing, clinical coordination, and network management. In the United States, spending on specialty biologics is estimated at $18 billion and projected to grow to $40 billion by 2010. In addition, health plans currently spend over $42 billion annually on home health, durable medical equipment and home infusion services. David Willcutts is founder and CEO of Ancillary Care Management. David was formerly an executive at Curaflex Health Services. Curaflex was a publicly-traded, leading provider of alternative site infusion therapy services generating over $100 million in revenue with operations in 21 states. Curaflex was acquired by Coram Healthcare in 1994. "Managing the costs of specialty biologics has become a priority for health plans. ACM has developed unique and superior systems and processes to facilitate the management of these ancillary costs," says Felsenthal. "Through its relationships with Medco and some of the country's leading health plans, ACM has established a very impressive platform that is well positioned to take advantage of this market opportunity."